ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

FUM Futura Medical Plc

40.50
1.70 (4.38%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Futura Medical Plc LSE:FUM London Ordinary Share GB0033278473 ORD 0.2P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.70 4.38% 40.50 39.70 40.50 40.00 39.00 39.60 359,491 16:35:16
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.85M -0.0194 -20.62 120.28M

Futura Medical PLC Total Voting Rights (9309P)

31/05/2018 6:20pm

UK Regulatory


Futura Medical (LSE:FUM)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Futura Medical Charts.

TIDMFUM

RNS Number : 9309P

Futura Medical PLC

31 May 2018

 
                            31 May 2018 
 

Futura Medical plc

("Futura" or "the Company")

Total Voting Rights

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, for the purposes of the FCA's Disclosure and Transparency Rules, the Company's total issued share capital at the date of this announcement is 121,006,002 Ordinary Shares.

Since the Company currently holds no shares in treasury, the total number of voting rights in the Company is 121,006,002 and this figure may therefore be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information please contact: For media enquiries please contact:

 
 
   Futura Medical plc Buchanan Communications Limited 
 Angela Hildreth, FD/COO Mark Court / Stephanie 
  Watson / 
  + 44 (0) 1483 685 670 Sophie Wills 
  angela.hildreth@futuramedical.com + 44 (0) 20 
  7466 5000 
  www.futuramedical.com 
 
 Nominated Adviser 
  N+1 Singer 
  Aubrey Powell / Liz Yong 
  +44 (0) 20 7496 3000 
 
 

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVRMMGFKNMLGRZM

(END) Dow Jones Newswires

May 31, 2018 13:20 ET (17:20 GMT)

1 Year Futura Medical Chart

1 Year Futura Medical Chart

1 Month Futura Medical Chart

1 Month Futura Medical Chart

Your Recent History

Delayed Upgrade Clock